Literature DB >> 6341242

Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk.

A B Otnaess, A Laegreid, K Ertresvåg.   

Abstract

Inhibitory activity of enterotoxin from Escherichia coli and Vibrio cholerae was associated with the ganglioside fraction of human milk. Both the milk fat and skim milk contained gangliosides that inhibited the toxins. The most purified milk fraction contained three glycolipid components, of which two migrated close to ganglioside GM1 on thin-layer chromatography plates. A component with a slightly different mobility from GM1 appeared to be associated with the inhibitory activity. Milk ganglioside fraction, derived from 2 ml of human milk, contained 1 to 4 micrograms of lipid-bound sialic acid and completely inhibited 0.1 micrograms of cholera toxin in rabbit intestinal loop experiments. It is suggested that human milk gangliosides, although present only in trace amounts, may be important in protecting infants against enterotoxin-induced diarrhea.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341242      PMCID: PMC264892          DOI: 10.1128/iai.40.2.563-569.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Host resistance factors in human milk.

Authors:  A S Goldman; C W Smith
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

2.  Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside.

Authors:  D A Wenger; S Wardell
Journal:  Physiol Chem Phys       Date:  1972

3.  Interaction of Vibrio cholerae enterotoxin with cell membranes.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

4.  Rocket immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

5.  Deactivation of cholera toxin by ganglioside.

Authors:  W E Van Heyningen; C C Carpenter; N F Pierce; W B Greenough
Journal:  J Infect Dis       Date:  1971-10       Impact factor: 5.226

6.  Inhibition of the steroidogenic effects of cholera and heat-labile Escherichia coli enterotoxins by GM1 ganglioside: evidence for a similar receptor site for the two toxins.

Authors:  S T Donta; J P Viner
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

Review 7.  Breast-feeding: second thoughts.

Authors:  J W Gerrard
Journal:  Pediatrics       Date:  1974-12       Impact factor: 7.124

8.  Comparison of the action of Escherichia coli enterotoxin on the thymocyte adenylate cyclase-cyclic adenosine monophosphate system to that of cholera toxin and prostaglandin E1.

Authors:  T V Zenser; J F Metzger
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

9.  Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids.

Authors:  J Holmgren; I Lönnroth; L Svennerholm
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

10.  Gangliosides of human, bovine, and rabbit plasma.

Authors:  R K Yu; R W Ledeen
Journal:  J Lipid Res       Date:  1972-09       Impact factor: 5.922

View more
  22 in total

1.  Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis.

Authors:  M Mouricout; J M Petit; J R Carias; R Julien
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  Factors in human milk that protect against diarrheal disease.

Authors:  L K Pickering; A L Morrow
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

Review 3.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

4.  Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells.

Authors:  Kari Shoaf; George L Mulvey; Glen D Armstrong; Robert W Hutkins
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 5.  Oligosaccharides and glycoconjugates in human milk: their role in host defense.

Authors:  D S Newburg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

Review 6.  [Structural and functional aspects of oligosaccharides in human milk].

Authors:  C Kunz; S Rudloff
Journal:  Z Ernahrungswiss       Date:  1996-03

7.  Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm.

Authors:  Maria Lorna A De Leoz; Stephanie C Gaerlan; John S Strum; Lauren M Dimapasoc; Majid Mirmiran; Daniel J Tancredi; Jennifer T Smilowitz; Karen M Kalanetra; David A Mills; J Bruce German; Carlito B Lebrilla; Mark A Underwood
Journal:  J Proteome Res       Date:  2012-08-28       Impact factor: 4.466

8.  Chemical and enzymatic transacylation of amide-linked FA of buttermilk gangliosides.

Authors:  Christopher Beermann; Anne-Katrin Röhrig; Günther Boehm
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

9.  Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin.

Authors:  Masao Iwamori; Kotarou Takamizawa; Mikio Momoeda; Yuriko Iwamori; Yuji Taketani
Journal:  Glycoconj J       Date:  2008-05-23       Impact factor: 2.916

10.  Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion.

Authors:  Y Yoshiyama; W R Brown
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.